Multicellular Tumor Spheroids for Evaluation of Cytotoxicity and Tumor Growth Inhibitory Effects of Nanomedicines In Vitro: A Comparison of Docetaxel-Loaded Block Copolymer Micelles and Taxotere®

Mikhail, Andrew S.; Eetezadi, Sina; Allen, Christine
April 2013
PLoS ONE;Apr2013, Vol. 8 Issue 4, p1
Academic Journal
While 3-D tissue models have received increasing attention over the past several decades in the development of traditional anti-cancer therapies, their potential application for the evaluation of advanced drug delivery systems such as nanomedicines has been largely overlooked. In particular, new insight into drug resistance associated with the 3-D tumor microenvironment has called into question the validity of 2-D models for prediction of in vivo anti-tumor activity. In this work, a series of complementary assays was established for evaluating the in vitro efficacy of docetaxel (DTX) -loaded block copolymer micelles (BCM+DTX) and Taxotere® in 3-D multicellular tumor spheroid (MCTS) cultures. Spheroids were found to be significantly more resistant to treatment than monolayer cultures in a cell line dependent manner. Limitations in treatment efficacy were attributed to mechanisms of resistance associated with properties of the spheroid microenvironment. DTX-loaded micelles demonstrated greater therapeutic effect in both monolayer and spheroid cultures in comparison to Taxotere®. Overall, this work demonstrates the use of spheroids as a viable platform for the evaluation of nanomedicines in conditions which more closely reflect the in vivo tumor microenvironment relative to traditional monolayer cultures. By adaptation of traditional cell-based assays, spheroids have the potential to serve as intermediaries between traditional in vitro and in vivo models for high-throughput assessment of therapeutic candidates.


Related Articles

  • A Novel Rapamycin-Polymer Conjugate Based on a New Poly(Ethylene Glycol) Multiblock Copolymer. Tai, Wanyi; Chen, Zhijin; Barve, Ashutosh; Peng, Zhonghua; Cheng, Kun // Pharmaceutical Research;Mar2014, Vol. 31 Issue 3, p706 

    Purpose: Rapamycin has demonstrated potent anti-tumor activity in preclinical and clinical studies. However, the clinical development of its formulations was hampered due to its poor solubility and undesirable distribution in vivo. Chemical modification of rapamycin presents an opportunity for...

  • Drug Release Patterns and Cytotoxicity of PEG-poly(aspartate) Block Copolymer Micelles in Cancer Cells. Eckman, Allison; Tsakalozou, Eleftheria; Kang, Nayon; Ponta, Andrei; Bae, Younsoo // Pharmaceutical Research;Jul2012, Vol. 29 Issue 7, p1755 

    Purpose: To test physicochemical and biological properties of PEG-poly(aspartate) [PEG-p(Asp)] block copolymer micelles entrapping doxorubicin hydrochloride (DOX) through ionic interaction. Methods: PEG-p(Asp) was synthesized from 5 kDa PEG and 20 Asp units. Carboxyl groups of p(Asp) were...

  • Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles. Oberoi, Hardeep S.; Nukolova, Natalia V.; Zhao, Yi; Cohen, Samuel M.; Kabanov, Alexander V.; Bronich, Tatiana K. // Chemotherapy Research & Practice;2012, p1 

    The therapeutic performance of oxaliplatin can be improved by incorporating the central cis-dichloro(1,2- diaminocyclohexane)platinum(II) (DACHPt) motif into the core cross-linked block copolymer micelles. We describe here the preparation, cellular uptake, and in vivo evaluation of core...

  • Enhancing cytotoxic agent activity in experimental pancreatic cancer through EMAP II combination therapy. Awasthi, Niranjan; Schwarz, Margaret; Schwarz, Roderich // Cancer Chemotherapy & Pharmacology;Sep2011, Vol. 68 Issue 3, p571 

    Purpose: Gemcitabine has limited benefits as single agent or in combination for pancreatic ductal adenocarcinoma (PDAC). Endothelial monocyte-activating polypeptide II (EMAP) enhances gemcitabine effects in PDAC. We evaluated the combination effects of EMAP, doxorubicin, and docetaxel in...

  • Docetaxel Loaded PEG-PLGA Nanoparticles: Optimized Drug Loading, In-vitro Cytotoxicity and In-vivo Antitumor Effect. Koopaei, Mona Noori; Khoshayand, Mohammad Reza; Mostafavi, Seyed Hossein; Amini, Mohsen; Khorramizadeh, Mohammad Reza; Tehrani, Mahmood Jeddi; Atyabi, Fatemeh; Dinarvand, Rassoul // Iranian Journal of Pharmaceutical Research;2014, Vol. 13 Issue 3, p819 

    In this study a 3-factor, 3-level Box-Behnken design was used to prepare optimized docetaxel (DTX) loaded pegylated poly lactide-co-glycolide (PEG-PLGA) NPs with polymer concentration (X1), drug concentration (X2) and ratio of the organic to aqueous solvent (X3) as the independent variables and...

  • Chloroethyl urea derivatives block tumour growth and thioredoxin-1 nuclear translocation. Patenaude, Alexandre; Fortin, Jessica S.; Deschenes, Réna; Côté, Marie-France; Lacroix, Jacques; C.-Gaudreault, René; Petitclerc, Éric // Canadian Journal of Physiology & Pharmacology;Nov2010, Vol. 88 Issue 11, p1102 

    Aryl chloroethyl ureas (CEUs) are new protein alkylating agents exhibiting anticancer activity both in vitro and in vivo. We report herein that 14C-labeled CEU derivatives, designated CEU-025 and CEU-027, covalently bind to thioredoxin-1 (TRX1). Covalent binding of these molecules slightly...

  • Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma. Maglioco, Andrea; Machuca, Damián; Mundiñano, Juliana; Cabrera, Gabriel; Camicia, Gabriela; Bruzzo, Juan; Camerano, Gabriela; Costa, Héctor; Ruggiero, Raúl; Dran, Graciela // Cancer Immunology, Immunotherapy;Mar2011, Vol. 60 Issue 3, p389 

    Tumor-draining lymph node (TDLN) ablation is routinely performed in the management of cancer; nevertheless, its usefulness is at present a matter of debate. TDLN are central sites where T cell priming to tumor antigens and onset of the antitumor immune response occur. However, tumor-induced...

  • Cytotoxity Evaluation of Docetaxel Nanoparticles by Culturing HepG2 Carcinoma Cell Lines. Shokrzadeh, Mohammad; Ebrahimnejad, Pedram; Omidi, Mahmood; Shadboorestan, Amir; Zalzar, Zavosh // Journal of Mazandaran University of Medical Sciences (JMUMS);Jul2012, Vol. 22 Issue 90, p2 

    Background and purpose: Human hepatocellular carcinoma (HCC) is one of the most common causes of death in the world. Targeted drug delivery to cells, tissues or specialized receptor cells is an advanced technology in treatment of HCC. The purpose of this study was to investigate the cytotoxicity...

  • Spatiotemporally Controlled Co-delivery of Anti-vasculature Agent and Cytotoxic Drug by Octreotide-Modified Stealth Liposomes. Dai, Wenbing; Jin, Wu; Zhang, Junlin; Wang, Xueqing; Wang, Jiancheng; Zhang, Xuan; Wan, You; Zhang, Qiang // Pharmaceutical Research;Oct2012, Vol. 29 Issue 10, p2902 

    Purpose: Both combretastatin A-4 (CA-4) and doxorubicin (DOX) was loaded in different form in a targeted nanomedicine in order to achieve the active delivery of these two drugs followed by sequentially suppressing tumor vasculature and tumor cells. Methods: Octreotide-modified stealth liposomes...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics